News

Scottish LMCs question safety of extended hours DES

29-Apr-08

The Scottish government has failed to give consideration to the security and safety of GPs in implementing the extended access directed enhanced service (DES), according to LMCs.

Dr Georgina Brown from Greater Glasgow and Clyde LMC told the Scottish LMCs conference in Clydebank last week that one in 10 UK doctors have been physically attacked in the last year.

Yet the amount of money provided by the government for extended hours was tiny, she said. 

‘It's our responsibility to protect ourselves and our patients but, at £2.95 per patient, how do we do that?'

GPC Scotland chairman Dr Dean Marshall said that the risk of attack facing GPs, staff and patients was high.

‘This is going to happen. It's just a matter of time,' he said.

GPletters@haymarket.com

Read all the latest news from the Scottish LMCs conference

Comment below and tell us what you think

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Healthcare Republic Forums

 

Registrar

A question of capacity

Medicolegal advisor, Dr John Holden addresses some dilemmas on consent that may be faced by GPs. Read more

Workplace-based assessment

The WPBA should be seen as a developmental process, says the RCGP's Dr Jane Mamelok. Read more

Professional development - The role of an educational supervisor

Working as an educational supervisor can be stimulating and rewarding, says Dr Alexander Williams. Read more

Show all articles

 

Latest Clinical Articles

Primary hyperparathyroidism

Contributed by Mr David Scott-Coombes, consultant endocrine surgeon at the University Hospital of Wa... Read more

Clinical Review - Headache in children

Contributed by Dr David Kernick, a GPSI in headache, based in Exeter. Read more

Carpal tunnel syndrome

Section 1: Epidemiology and aetiology Read more

Show all clinical articles

MIMS Product News

Toviaz

New drug - Toviaz

Pfizer has launched Toviaz (fesoterodine), a once-daily treatment for the symptoms of overactive bla... Read more

New drug - Tasigna

Novartis has launched Tasigna (nilotinib), a new antineoplastic agent for Philadelphia chromosome po... Read more

Ciproxin licensed for UTI in children

The licence for Ciproxin (ciprofloxacin) has been extended to include the second- and third-line tr... Read more

Jobs

 

Job of the Week